Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-9-29
pubmed:abstractText
There is increasing evidence of cross-talk between renin-angiotensin system (RAS) and dyslipidemia in atherogenesis mediated via activation of inflammatory cascade, involving CD40 and matrix metalloproteinases (MMPs). We postulated that inhibition of RAS with candesartan and dyslipidemia with rosuvastatin would have additive inhibitory effect on CD40 and MMPs expression and atherogenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD40, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E, http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinases, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of..., http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of..., http://linkedlifedata.com/resource/pubmed/chemical/candesartan, http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0160-2446
pubmed:author
pubmed:issnType
Print
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
446-52
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15454852-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:15454852-Animals, pubmed-meshheading:15454852-Antigens, CD40, pubmed-meshheading:15454852-Apolipoproteins E, pubmed-meshheading:15454852-Arteriosclerosis, pubmed-meshheading:15454852-Benzimidazoles, pubmed-meshheading:15454852-Cholesterol, pubmed-meshheading:15454852-Drug Synergism, pubmed-meshheading:15454852-Drug Therapy, Combination, pubmed-meshheading:15454852-Female, pubmed-meshheading:15454852-Fluorobenzenes, pubmed-meshheading:15454852-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:15454852-Hyperlipidemias, pubmed-meshheading:15454852-Male, pubmed-meshheading:15454852-Matrix Metalloproteinases, pubmed-meshheading:15454852-Mice, pubmed-meshheading:15454852-Mice, Inbred C57BL, pubmed-meshheading:15454852-Mice, Knockout, pubmed-meshheading:15454852-Pyrimidines, pubmed-meshheading:15454852-RNA, Messenger, pubmed-meshheading:15454852-Renin-Angiotensin System, pubmed-meshheading:15454852-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15454852-Sulfonamides, pubmed-meshheading:15454852-Tetrazoles, pubmed-meshheading:15454852-Tissue Inhibitor of Metalloproteinase-1, pubmed-meshheading:15454852-Tissue Inhibitor of Metalloproteinase-2
pubmed:year
2004
pubmed:articleTitle
Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis.
pubmed:affiliation
Department of Internal Medicine, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205-7199, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't